Easy Access and Express Report Delivery Service
This report aims to provide a comprehensive presentation of the global market for Peanut Allergy Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peanut Allergy Therapeutics. The Peanut Allergy Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Peanut Allergy Therapeutics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Peanut Allergy Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions. Key Companies & Market Share Insights In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include: Mylan Bayer UCB Pharma J & J Perrigo GSK Kaleo Amneal Pharma ALK Abello Aimmune Therapeutics HUAPONT Pharm Allergy Therapeutics ASIT Biotech Sanofi DBV Technologies HAL Allergy Intrommune Therapeutics Product Type Insights Global markets are presented by Peanut Allergy Therapeutics type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Peanut Allergy Therapeutics are procured by the companies. This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029). Peanut Allergy Therapeutics segment by Type Epinephrine Injection Antihistamines Oral Immunotherapy Other Application Insights This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029). This report also outlines the market trends of each segment and consumer behaviors impacting the Peanut Allergy Therapeutics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Peanut Allergy Therapeutics market. Peanut Allergy Therapeutics Segment by Distribution Channel Hospital Pharmacy Retail Pharmacy Other Regional Outlook This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029. The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029. North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. COVID-19 and Russia-Ukraine War Influence Analysis The readers in the section will understand how the Peanut Allergy Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come. Reasons to Buy This Report This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. This report stays updated with novel technology integration, features, and the latest developments in the market This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Peanut Allergy Therapeutics industry. This report helps stakeholders to gain insights into which regions to target globally This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Core Chapters Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of Peanut Allergy Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report.
1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Peanut Allergy Therapeutics by Type 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) 1.2.2 Epinephrine Injection 1.2.3 Antihistamines 1.2.4 Oral Immunotherapy 1.2.5 Other 2.3 Peanut Allergy Therapeutics by Distribution Channel 2.3.1 Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029) 2.3.2 Hospital Pharmacy 2.3.3 Retail Pharmacy 2.3.4 Other 2.4 Assumptions and Limitations 3 Peanut Allergy Therapeutics Breakdown Data by Type 3.1 Global Peanut Allergy Therapeutics Historic Market Size by Type (2018-2023) 3.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2023-2028) 4 Peanut Allergy Therapeutics Breakdown Data by Distribution Channel 4.1 Global Peanut Allergy Therapeutics Historic Market Size by Distribution Channel (2018-2023) 4.2 Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2018-2023) 5 Global Growth Trends 5.1 Global Peanut Allergy Therapeutics Market Perspective (2018-2029) 5.2 Global Peanut Allergy Therapeutics Growth Trends by Region 5.2.1 Global Peanut Allergy Therapeutics Market Size by Region: 2018 VS 2022 VS 2029 5.2.2 Peanut Allergy Therapeutics Historic Market Size by Region (2018-2023) 5.2.3 Peanut Allergy Therapeutics Forecasted Market Size by Region (2024-2029) 5.3 Peanut Allergy Therapeutics Market Dynamics 5.3.1 Peanut Allergy Therapeutics Industry Trends 5.3.2 Peanut Allergy Therapeutics Market Drivers 5.3.3 Peanut Allergy Therapeutics Market Challenges 5.3.4 Peanut Allergy Therapeutics Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Peanut Allergy Therapeutics Players by Revenue 6.1.1 Global Top Peanut Allergy Therapeutics Players by Revenue (2018-2023) 6.1.2 Global Peanut Allergy Therapeutics Revenue Market Share by Players (2018-2023) 6.2 Global Peanut Allergy Therapeutics Industry Players Ranking, 2021 VS 2022 VS 2023 6.3 Global Key Players of Peanut Allergy Therapeutics Head office and Area Served 6.4 Global Peanut Allergy Therapeutics Players, Product Type & Application 6.5 Global Peanut Allergy Therapeutics Players, Date of Enter into This Industry 6.6 Global Peanut Allergy Therapeutics Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Peanut Allergy Therapeutics Market Size (2018-2029) 7.2 North America Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 North America Peanut Allergy Therapeutics Market Size by Country (2018-2023) 7.4 North America Peanut Allergy Therapeutics Market Size by Country (2024-2029) 7.5 United States 7.6 Canada 8 Europe 8.1 Europe Peanut Allergy Therapeutics Market Size (2018-2029) 8.2 Europe Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 8.3 Europe Peanut Allergy Therapeutics Market Size by Country (2018-2023) 8.4 Europe Peanut Allergy Therapeutics Market Size by Country (2024-2029) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Peanut Allergy Therapeutics Market Size (2018-2029) 9.2 Asia-Pacific Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2018-2023) 9.4 Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2024-2029) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 10 Latin America 10.1 Latin America Peanut Allergy Therapeutics Market Size (2018-2029) 10.2 Latin America Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Latin America Peanut Allergy Therapeutics Market Size by Country (2018-2023) 10.4 Latin America Peanut Allergy Therapeutics Market Size by Country (2024-2029) 9.4 Mexico 9.5 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Peanut Allergy Therapeutics Market Size (2018-2029) 11.2 Middle East & Africa Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 11.3 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2018-2023) 11.4 Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2024-2029) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 12 Players Profiled 11.1 Mylan 11.1.1 Mylan Company Detail 11.1.2 Mylan Business Overview 11.1.3 Mylan Peanut Allergy Therapeutics Introduction 11.1.4 Mylan Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.1.5 Mylan Recent Development 11.2 Bayer 11.2.1 Bayer Company Detail 11.2.2 Bayer Business Overview 11.2.3 Bayer Peanut Allergy Therapeutics Introduction 11.2.4 Bayer Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.2.5 Bayer Recent Development 11.3 UCB Pharma 11.3.1 UCB Pharma Company Detail 11.3.2 UCB Pharma Business Overview 11.3.3 UCB Pharma Peanut Allergy Therapeutics Introduction 11.3.4 UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.3.5 UCB Pharma Recent Development 11.4 J & J 11.4.1 J & J Company Detail 11.4.2 J & J Business Overview 11.4.3 J & J Peanut Allergy Therapeutics Introduction 11.4.4 J & J Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.4.5 J & J Recent Development 11.5 Perrigo 11.5.1 Perrigo Company Detail 11.5.2 Perrigo Business Overview 11.5.3 Perrigo Peanut Allergy Therapeutics Introduction 11.5.4 Perrigo Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.5.5 Perrigo Recent Development 11.6 GSK 11.6.1 GSK Company Detail 11.6.2 GSK Business Overview 11.6.3 GSK Peanut Allergy Therapeutics Introduction 11.6.4 GSK Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.6.5 GSK Recent Development 11.7 Kaleo 11.7.1 Kaleo Company Detail 11.7.2 Kaleo Business Overview 11.7.3 Kaleo Peanut Allergy Therapeutics Introduction 11.7.4 Kaleo Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.7.5 Kaleo Recent Development 11.8 Amneal Pharma 11.8.1 Amneal Pharma Company Detail 11.8.2 Amneal Pharma Business Overview 11.8.3 Amneal Pharma Peanut Allergy Therapeutics Introduction 11.8.4 Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.8.5 Amneal Pharma Recent Development 11.9 ALK Abello 11.9.1 ALK Abello Company Detail 11.9.2 ALK Abello Business Overview 11.9.3 ALK Abello Peanut Allergy Therapeutics Introduction 11.9.4 ALK Abello Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.9.5 ALK Abello Recent Development 11.10 Aimmune Therapeutics 11.10.1 Aimmune Therapeutics Company Detail 11.10.2 Aimmune Therapeutics Business Overview 11.10.3 Aimmune Therapeutics Peanut Allergy Therapeutics Introduction 11.10.4 Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.10.5 Aimmune Therapeutics Recent Development 11.11 HUAPONT Pharm 11.11.1 HUAPONT Pharm Company Detail 11.11.2 HUAPONT Pharm Business Overview 11.11.3 HUAPONT Pharm Peanut Allergy Therapeutics Introduction 11.11.4 HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.11.5 HUAPONT Pharm Recent Development 11.12 Allergy Therapeutics 11.12.1 Allergy Therapeutics Company Detail 11.12.2 Allergy Therapeutics Business Overview 11.12.3 Allergy Therapeutics Peanut Allergy Therapeutics Introduction 11.12.4 Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.12.5 Allergy Therapeutics Recent Development 11.13 ASIT Biotech 11.13.1 ASIT Biotech Company Detail 11.13.2 ASIT Biotech Business Overview 11.13.3 ASIT Biotech Peanut Allergy Therapeutics Introduction 11.13.4 ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.13.5 ASIT Biotech Recent Development 11.14 Sanofi 11.14.1 Sanofi Company Detail 11.14.2 Sanofi Business Overview 11.14.3 Sanofi Peanut Allergy Therapeutics Introduction 11.14.4 Sanofi Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.14.5 Sanofi Recent Development 11.15 DBV Technologies 11.15.1 DBV Technologies Company Detail 11.15.2 DBV Technologies Business Overview 11.15.3 DBV Technologies Peanut Allergy Therapeutics Introduction 11.15.4 DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.15.5 DBV Technologies Recent Development 11.16 HAL Allergy 11.16.1 HAL Allergy Company Detail 11.16.2 HAL Allergy Business Overview 11.16.3 HAL Allergy Peanut Allergy Therapeutics Introduction 11.16.4 HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.16.5 HAL Allergy Recent Development 11.17 Intrommune Therapeutics 11.17.1 Intrommune Therapeutics Company Detail 11.17.2 Intrommune Therapeutics Business Overview 11.17.3 Intrommune Therapeutics Peanut Allergy Therapeutics Introduction 11.17.4 Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2017-2022) 11.17.5 Intrommune Therapeutics Recent Development 13 Report Conclusion 14 Disclaimer